GGrantIndex
Sort

48,018 grants matching immunotherapy

Posttranscriptional control of gene expression

$548,767
Barbara Felber · Basic Sciences · Z01 · FY2007 · CA

Developing new therapeutic strategies for brain metastasis

$548,753
Eva Hernando · New York University School Of Medicine · R01 · FY2025 · CA

Deciphering the molecular control of intratumoral dendritic cells

$548,745
Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA

Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity

$548,714
Vinod P Balachandran · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

Sunitinib Modulation of Cancer Immunotherapy

$548,705
James H Finke · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · CA

Project 3

$548,644
Branden S Moriarity · University Of Minnesota · P01 · FY2025 · CA

Project 3

$548,644
Branden S Moriarity · University Of Minnesota · P01 · FY2021 · CA

Genetic Approaches to Optimize CAR T cells for Glioblastoma Therapy

$548,582
Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2018 · NS

Lymph node-targeted multistage chemoimmunotherapy for lymphoma

$548,563
Susan Napier Thomas · Georgia Institute Of Technology · R01 · FY2023 · CA

Expanding the cancer paralog genetic interaction map to enable precision oncology

$548,562
Alice Berger · Fred Hutchinson Cancer Center · R01 · FY2025 · CA

Dectin-1 signaling drives pancreatic oncogenesis by inducing macrophage-mediated adaptive immune suppression

$548,509
Kwok Kin Wong · New York University School Of Medicine · R01 · FY2020 · CA

The role of natural killer cells and antibodies in protection from malaria

$548,492
Geoffrey T Hart · University Of Minnesota · R01 · FY2020 · AI

Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection

$548,418
Ginny L Bumgardner · Ohio State University · R01 · FY2019 · AI

Understanding human neutralizing antibodies to hepatitis C virus

$548,397
Mansun Law · Scripps Research Institute, The · R01 · FY2014 · AI

Understanding human neutralizing antibodies to hepatitis C virus

$548,397
Mansun Law · Scripps Research Institute, The · R01 · FY2015 · AI

Direct and indirect impacts of HIV and ART among older people in community settin

$548,393
Ties Boerma · World Health Organization · R01 · FY2016 · AG

Genetically Engineered Viruses for Brain Tumor Therapy

$548,365
Robert L Martuza · Massachusetts General Hospital · R01 · FY2022 · NS

Genetically Engineered Viruses for Brain Tumor Therapy

$548,365
Robert L Martuza · Massachusetts General Hospital · R01 · FY2019 · NS

Genetically Engineered Viruses for Brain Tumor Therapy

$548,365
Robert L Martuza · Massachusetts General Hospital · R01 · FY2021 · NS

Genetically Engineered Viruses for Brain Tumor Therapy

$548,365
Robert L Martuza · Massachusetts General Hospital · R01 · FY2020 · NS

Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction

$548,342
Amy E Moran · Oregon Health & Science University · R37 · FY2021 · CA

B cell subsets and immunity to cryptococcosis

$548,281
Liise-Anne Pirofski · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · AI

Project 3: Combinatorial and gene-editing approaches to enhance the efficacy of CAR T cell therapy of multiple myeloma.

$548,256
Edward A Stadtmauer · University Of Pennsylvania · P01 · FY2018 · CA

The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.

$548,247
John Ross Teijaro · Scripps Research Institute, The · R01 · FY2023 · AI

The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.

$548,247
John Ross Teijaro · Scripps Research Institute, The · R01 · FY2024 · AI